Also consistent with our observation in the HaCaT model, changes in EGFR mRNA expression in cetuximab treated HNSCC cells relative to control samples are associated with higher cell survival (p-value for one-sided Pearson correlation test of 0.11, Figure 5A). Here, EGFR is linked to head and neck squamous cell carcinoma.